Tofflon Italy

Company Profile Tofflon Science and Technology Group Co. Ltd.(Short for “Tofflon”, Stock Code: SZ 300171) was founded in 1993. It is a comprehensive pharmaceutical equipment supplier to provide process support, core equipments, integrated system and pharma engineering for the pharma and biotech industry in the world. Since its foundation, Tofflon has supplied more than equipments and systems for pharmaceutical companies across over 40 countries and regions in the world which have been widely applied in the fields of liquid and Lyo injectables, chemical API, bioengineering and pharma packaging. Tofflon focuses on studying drug manufacture science and process equipment manufacture science, practices drug process knowledge integration with pharma equipment knowledge. Taking “Synergy Global Advanced Technologies” strategy, Tofflon builds comprehensive development institute in Shanghai headquarters, is building design houses and technical centers in USA, Europe and India, establishes joint ventures and technology collaboration with the technical partners from USA, Europe and Japan. Tofflon dedicate itself to grow up to a total solution provider of pharmaceutical manufacturing systems and engineering for the global pharma and biotech industry to contribute to the maximum benefits and welfare of society, customers, stockholders, employees and their families. To achieve this goal and enter the European market permanently, in 2019 Tofflon Italy was born. The aim is offering assistance and localized technical support to European customers. There are two main Italian locations: the first is in Lombardy, in the province of Bergamo, and the second is in Piedmont, in the province of Novara.